ifosfamide has been researched along with Extranodal NK-T-Cell Lymphoma in 41 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients having rheumatoid arthritis (RA) treated with methotrexate (MTX) are at an increased risk of developing lymphoproliferative disorder (LPD)." | 3.81 | Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs. ( Fukayama, M; Koda, K; Tajima, S; Takanashi, Y, 2015) |
| "The aim of this study was to compare asparaginase-related toxicities in two asparaginase preparations, namely native Escherichia coli L-asparaginase (L-ASP) and pegylated asparaginase (PEG-ASP) in combination with ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) in natural killer (NK)/T-cell lymphoma (NTCL)." | 1.48 | Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type. ( Cho, YS; Heo, DS; Jung, SH; Keam, B; Kim, DW; Kim, HJ; Kim, IH; Kim, M; Kim, TM; Lee, JY; Lee, SH; Ock, CY, 2018) |
| "However, some patients experience early disease progression." | 1.48 | Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy. ( Amaki, J; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Katayama, N; Kim, SJ; Kim, WS; Ko, YH; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Oguchi, M; Saito, B; Shimada, K; Shimoda, E; Soejima, T; Suzuki, R; Terui, Y; Tsukamoto, N; Utsumi, T; Yamaguchi, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (17.07) | 29.6817 |
| 2010's | 29 (70.73) | 24.3611 |
| 2020's | 5 (12.20) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, K | 4 |
| Suzuki, R | 8 |
| Oguchi, M | 5 |
| Taguchi, S | 1 |
| Amaki, J | 4 |
| Maeda, T | 4 |
| Kubota, N | 4 |
| Maruyama, D | 2 |
| Terui, Y | 2 |
| Sekiguchi, N | 3 |
| Takizawa, J | 4 |
| Tsukamoto, H | 1 |
| Murayama, T | 2 |
| Ando, T | 3 |
| Matsuoka, H | 2 |
| Hasegawa, M | 2 |
| Wada, H | 3 |
| Sakai, R | 2 |
| Kameoka, Y | 2 |
| Tsukamoto, N | 2 |
| Choi, I | 2 |
| Masaki, Y | 2 |
| Shimada, K | 2 |
| Fukuhara, N | 2 |
| Utsumi, T | 2 |
| Uoshima, N | 1 |
| Kagami, Y | 2 |
| Asano, N | 4 |
| Ejima, Y | 3 |
| Katayama, N | 4 |
| Yamaguchi, M | 9 |
| Fujii, T | 1 |
| Ohno, N | 1 |
| Kitahara, S | 1 |
| Kobayashi, S | 1 |
| Sahara, N | 1 |
| Sakamoto, N | 1 |
| Arahira, S | 1 |
| Matsunaga, T | 1 |
| Sánchez-Romero, C | 1 |
| Paes de Almeida, O | 1 |
| Díaz Molina, JP | 1 |
| Carlos, R | 1 |
| Wei, L | 1 |
| Wang, L | 1 |
| Cong, J | 1 |
| Yang, L | 1 |
| Ye, J | 1 |
| Li, X | 2 |
| Yao, N | 1 |
| Yang, J | 2 |
| Wang, J | 2 |
| Ghione, P | 1 |
| Qi, S | 1 |
| Imber, BS | 1 |
| Seshan, V | 1 |
| Moskowitz, A | 1 |
| Galasso, N | 1 |
| Lunning, M | 1 |
| Straus, D | 1 |
| Sauter, C | 1 |
| Dahi, P | 1 |
| Dogan, A | 1 |
| Yahalom, J | 1 |
| Horwitz, S | 1 |
| Kim, HJ | 1 |
| Ock, CY | 1 |
| Kim, TM | 2 |
| Lee, SH | 2 |
| Lee, JY | 1 |
| Jung, SH | 1 |
| Cho, YS | 1 |
| Kim, M | 2 |
| Keam, B | 2 |
| Kim, DW | 3 |
| Kim, IH | 1 |
| Heo, DS | 3 |
| Kim, SJ | 7 |
| Ko, YH | 5 |
| Kobayashi, Y | 4 |
| Soejima, T | 1 |
| Saito, B | 3 |
| Shimoda, E | 1 |
| Kim, WS | 8 |
| Watanabe, J | 1 |
| Makita, S | 1 |
| Ito, Y | 2 |
| Hatta, S | 1 |
| Suzuki, T | 2 |
| Yuda, S | 1 |
| Maeshima, AM | 1 |
| Fukuhara, S | 1 |
| Munakata, W | 1 |
| Kim, SW | 1 |
| Izutsu, K | 3 |
| Kinoshita, S | 1 |
| Tomita, N | 2 |
| Niitsu, N | 1 |
| Hildyard, C | 1 |
| Sheikh, S | 1 |
| Eyre, T | 1 |
| Collins, G | 1 |
| So, JC | 1 |
| Chan, KH | 1 |
| Pang, AW | 1 |
| Chan, JK | 1 |
| Kwong, YL | 3 |
| Saburi, M | 1 |
| Itani, K | 1 |
| Nagamatsu, K | 1 |
| Miyazaki, Y | 1 |
| Otsuka, E | 1 |
| Urabe, S | 1 |
| Saburi, Y | 1 |
| Ji, J | 1 |
| Liu, T | 1 |
| Xiang, B | 1 |
| Liu, W | 1 |
| He, C | 1 |
| Chen, X | 1 |
| Li, J | 1 |
| Chang, H | 1 |
| Dai, Y | 1 |
| Dong, T | 1 |
| Park, S | 2 |
| Kang, ES | 2 |
| Choi, JY | 1 |
| Lim, DH | 1 |
| Kim, KH | 1 |
| Lee, JS | 1 |
| Jeon, YK | 1 |
| Kim, CW | 2 |
| Shi, Y | 1 |
| He, X | 1 |
| Dong, M | 1 |
| Zhang, C | 1 |
| Liu, P | 1 |
| Zhou, S | 1 |
| Qin, Y | 1 |
| Gui, L | 1 |
| Yang, S | 1 |
| Sun, Y | 1 |
| Tajima, S | 1 |
| Takanashi, Y | 1 |
| Koda, K | 1 |
| Fukayama, M | 1 |
| Oh, D | 1 |
| Ahn, YC | 2 |
| Dong, LH | 1 |
| Zhang, LJ | 1 |
| Wang, WJ | 1 |
| Lei, W | 1 |
| Sun, X | 1 |
| Du, JW | 1 |
| Gao, X | 1 |
| Li, GP | 1 |
| Li, YF | 1 |
| McEachron, TA | 1 |
| Kirov, I | 1 |
| Wungwattana, M | 1 |
| Cortes, D | 1 |
| Zabokrtsky, KB | 1 |
| Sassoon, A | 1 |
| Craig, D | 1 |
| Carpten, JD | 1 |
| Sender, LS | 1 |
| Cui, Y | 1 |
| Sun, Z | 1 |
| Zhang, L | 1 |
| Li, L | 1 |
| Wang, X | 1 |
| Wu, J | 1 |
| Fu, X | 1 |
| Ma, W | 1 |
| Zhang, X | 1 |
| Chang, Y | 1 |
| Nan, F | 1 |
| Li, W | 1 |
| Su, L | 1 |
| Xue, H | 1 |
| Zhang, M | 1 |
| Jung, KS | 1 |
| Cho, SH | 1 |
| Yoon, DH | 1 |
| Jeong, SH | 1 |
| Shin, DY | 1 |
| Bae, SH | 1 |
| Hong, J | 1 |
| Park, SK | 1 |
| Yhim, HY | 1 |
| Yang, DH | 1 |
| Lee, H | 1 |
| Kang, HJ | 1 |
| Lee, MH | 1 |
| Eom, HS | 2 |
| Kwak, JY | 1 |
| Lee, JH | 1 |
| Suh, C | 2 |
| Al Shawabkeh, MA | 1 |
| Al Sulaiti, M | 1 |
| Al Sa'ey, H | 1 |
| Ganesan, S | 1 |
| Akiba, T | 1 |
| Itasaka, S | 1 |
| Saito, Y | 1 |
| Itami, J | 1 |
| Ueda, K | 1 |
| Ii, N | 1 |
| Hyo, R | 2 |
| Celentano, A | 1 |
| Mascolo, M | 1 |
| Cirillo, N | 1 |
| De Rosa, G | 1 |
| Mignogna, MD | 1 |
| Mizuno, H | 1 |
| Koya, J | 1 |
| Fujioka, Y | 1 |
| Ibaraki, T | 1 |
| Nakamura, F | 2 |
| Hayashi, A | 1 |
| Shinozaki-Ushiku, A | 1 |
| Akamatsu, N | 1 |
| Hasegawa, K | 1 |
| Kokudo, N | 1 |
| Fukuyama, M | 1 |
| Kurokawa, M | 2 |
| Kim, BS | 2 |
| Im, SA | 1 |
| Kim, TY | 1 |
| Yoon, SS | 1 |
| Bang, YJ | 1 |
| Kim, BK | 1 |
| Kim, NK | 1 |
| Kato, T | 1 |
| Tanabe, J | 1 |
| Kanemoto, M | 1 |
| Kobayashi, C | 1 |
| Morita, S | 1 |
| Karahashi, T | 1 |
| Tobinai, K | 1 |
| Ishizuka, N | 1 |
| Isobe, Y | 2 |
| Ishizawa, K | 1 |
| Maseki, N | 1 |
| Itoh, K | 1 |
| Usui, N | 1 |
| Wasada, I | 1 |
| Kinoshita, T | 1 |
| Ohshima, K | 1 |
| Matsuno, Y | 1 |
| Terauchi, T | 1 |
| Nawano, S | 1 |
| Ishikura, S | 1 |
| Hotta, T | 1 |
| Oshimi, K | 3 |
| Kim, K | 1 |
| Kim, CY | 1 |
| Huh, J | 1 |
| Lee, SW | 1 |
| Kim, JS | 1 |
| Cho, J | 1 |
| Lee, GW | 1 |
| Kang, KM | 1 |
| Pyo, HR | 1 |
| Inoue, D | 1 |
| Nagai, Y | 1 |
| Takiuchi, Y | 1 |
| Nagano, S | 1 |
| Arima, H | 1 |
| Kimura, T | 1 |
| Shimoji, S | 1 |
| Mori, M | 1 |
| Togami, K | 1 |
| Tabata, S | 1 |
| Yanagita, S | 1 |
| Matsushita, A | 1 |
| Nagai, K | 1 |
| Maruoka, H | 1 |
| Imai, Y | 2 |
| Takahashi, T | 1 |
| Farid, M | 1 |
| Yau, YW | 1 |
| Tay, K | 1 |
| Quek, R | 1 |
| Tao, M | 1 |
| Koo, GC | 1 |
| Loong, S | 1 |
| Lim, ST | 2 |
| Kimura, H | 1 |
| Maeda, Y | 1 |
| Hashimoto, C | 1 |
| Ishida, F | 1 |
| Fukushima, N | 1 |
| Hasegawa, Y | 2 |
| Kobayashi, H | 2 |
| Okamura, S | 1 |
| Suzumiya, J | 2 |
| Nakamura, S | 2 |
| Kawa, K | 2 |
| Tang, T | 1 |
| Tse, E | 1 |
| Leung, AY | 1 |
| Chim, CS | 1 |
| Kobayashi, T | 1 |
| Hangaishi, A | 1 |
| Yamamoto, G | 1 |
| Shinohara, A | 1 |
| Morikawa, T | 1 |
| Takazawa, Y | 1 |
| Ota, S | 1 |
| Okamura, T | 1 |
| Wills, AJ | 1 |
| O'Connor, S | 1 |
| McMillan, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Multi-center Clinical Trial on Treatment of Stage Ⅲ/Ⅳ NK/T Cell Lymphoma With DDGP Regiment (Gemcitabine,Pegaspargase,Cisplatin,Dexamethasone)[NCT01501149] | Phase 4 | 80 participants (Anticipated) | Interventional | 2011-01-31 | Recruiting | ||
| Efficacy and Safety of Brentuximab Vedotin in Combination With Tislelizumab for the Treatment of CD30-positive Relapsed/Refractory NK/T-cell Lymphoma[NCT05316246] | Phase 2 | 40 participants (Anticipated) | Interventional | 2022-06-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ifosfamide and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
[Treatment of localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Moda | 2008 |
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; | 2010 |
Current and future management of NK/T-cell lymphoma based on clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Clinic | 2012 |
8 trials available for ifosfamide and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2019 |
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; D | 2016 |
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cispla | 2016 |
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Su | 2009 |
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplati | 2009 |
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexa | 2009 |
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; E | 2012 |
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone | 2008 |
30 other studies available for ifosfamide and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Central Nervous System; D | 2022 |
[Extranodal NK/T cell lymphoma, nasal type with local recurrence in the contralateral nasal cavity 15 years after initial sequential chemoradiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Female; Human | 2022 |
Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma; Chemorad | 2020 |
SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone | 2020 |
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Humans; Ifosfamide; Lym | 2020 |
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Escherichia coli; Etoposide; Fem | 2018 |
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbopla | 2018 |
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Dexamethasone; Drug Resis | 2018 |
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Cerebrospinal Fluid | 2013 |
Diagnosis of brainstem involvement in NK/T cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; | 2014 |
[Successful treatment with high-dose methotrexate/cytarabine regimen in a patient in SMILE regimen-resistant extranodal natural killer/T-cell lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Dexamethasone; Drug | 2014 |
A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Dexamethasone; Etoposid | 2014 |
Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cohort Studie | 2015 |
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Fe | 2015 |
A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dexamethason | 2015 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Vi | 2015 |
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Chemoradiotherapy; Cisplati | 2015 |
Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiothe | 2016 |
Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cytarabine; | 2016 |
L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Moda | 2016 |
Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diagnosis, Differential; Etopo | 2016 |
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2017 |
Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chronic Disease; Delayed Diagno | 2017 |
Extranodal NK/T cell lymphoma in a living donor liver transplant recipient.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Substi | 2017 |
A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Dexamethasone | 2009 |
Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transpl
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemotherapy, Adjuvant; Combine | 2010 |
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Deoxycytidine; Fem | 2011 |
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinic | 2012 |
Successful treatment of secondary NK/T-cell lymphoma of the testis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexame | 2013 |
Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Demyeli | 2008 |